Moreover, IgG-mediated IpaB-specific Fc-effector profiles prior to infection were linked to protection, whereas post-infection IgA-mediated activity was associated with clinical protection, indicating distinct temporal antibody-associated protective mechanisms. This evidence concerns the gene CD79A and infection.